Published in J Steroid Biochem Mol Biol on March 01, 1992
Obesity and metabolic comorbidities: environmental diseases? Oxid Med Cell Longev (2013) 0.88
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature (1997) 2.03
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate (1996) 1.85
AME position statement on adrenal incidentaloma. Eur J Endocrinol (2011) 1.82
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med (2008) 1.63
A new case of Ambras syndrome associated with a paracentric inversion (8) (q12; q22) Clin Genet (1998) 1.57
Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable? BJU Int (2003) 1.50
Two different pathogenetic mechanisms may play a role in acne and in hirsutism. Clin Endocrinol (Oxf) (1993) 1.46
Leydig cell loss and spermatogenic arrest in platelet-derived growth factor (PDGF)-A-deficient mice. J Cell Biol (2000) 1.44
Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene (2008) 1.41
Cyclic AMP regulates the HERG K(+) channel by dual pathways. Curr Biol (2000) 1.39
Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract (2010) 1.36
A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule. Endoscopy (2005) 1.26
Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. Proc Natl Acad Sci U S A (2005) 1.19
Insulation lead failure: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol (1998) 1.18
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. Diabet Med (2008) 1.17
The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice. Br J Pharmacol (2009) 1.16
Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med (1992) 1.14
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro. Bone (2002) 1.14
Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J Clin Endocrinol Metab (1995) 1.13
Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res (2006) 1.09
Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr Rev (1997) 1.09
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrinol (2004) 1.08
Paradoxical allosteric effects of competitive inhibitors on neuronal alpha7 nicotinic receptor mutants. Neuroreport (1997) 1.07
Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action. J Cell Biol (1995) 1.07
Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer. J Endocrinol (2007) 1.07
Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol (2001) 0.99
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol (1991) 0.99
Human neuronal threonine-for-leucine-248 alpha 7 mutant nicotinic acetylcholine receptors are highly Ca2+ permeable. Proc Natl Acad Sci U S A (2000) 0.99
Alpha 5 subunit forms functional alpha 3 beta 4 alpha 5 nAChRs in transfected human cells. Neuroreport (1997) 0.98
Inhibition of nicotinic acetylcholine receptors by bicuculline. Neuropharmacology (2001) 0.97
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate (1998) 0.96
Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch Virol (1997) 0.95
Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J Exp Clin Cancer Res (1998) 0.94
The application of digital pulse amplitude tonometry to the diagnostic investigation of endothelial dysfunction in men with erectile dysfunction. Andrologia (2010) 0.94
Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J Pathol (1999) 0.94
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. J Endocrinol Invest (2010) 0.94
Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol (1992) 0.93
Clustering of autoimmune thyroid diseases in children and adolescents: a study of 66 families. J Pediatr Endocrinol Metab (2001) 0.93
Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes (Lond) (2010) 0.93
The IGF axis in prostate cancer. Curr Pharm Des (2007) 0.93
Change in cardiovascular risk factors during a 10-year community intervention program. Acta Cardiol (1997) 0.92
Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells. Nucleic Acids Res (1990) 0.92
Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res (2001) 0.91
Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information. Prog Neurobiol (2009) 0.91
Two forms of acetylcholine receptor gamma subunit in mouse muscle. Proc Natl Acad Sci U S A (1995) 0.90
Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res (2009) 0.90
DNA--protein crosslinks, a biomarker of exposure to formaldehyde--in vitro and in vivo studies. Carcinogenesis (1996) 0.89
Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis. J Med Genet (2002) 0.89
Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab (1996) 0.89
Leiomyosarcoma of urinary bladder: personal experience in 3 cases over a 10-year period. Arch Ital Urol Androl (1997) 0.88
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation. BJU Int (2004) 0.87
Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer. J Exp Clin Cancer Res (2000) 0.87
Stemness and osteogenic and adipogenic potential are differently impaired in subcutaneous and visceral adipose derived stem cells (ASCs) isolated from obese donors. Int J Immunopathol Pharmacol (2013) 0.87
Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization. J Cell Physiol (2009) 0.87
Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines. Prostate (1996) 0.87
Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. Prostate (1998) 0.87
Prolactin release in polycystic ovary. Obstet Gynecol (1980) 0.86
Epidermal growth factor binding sites in human pituitary macroadenomas. J Endocrinol (1998) 0.86
Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis. J Biol Regul Homeost Agents (2009) 0.86
Importance and evaluation of comorbidity in rehabilitation. Disabil Rehabil (2001) 0.86
Pachydermoperiostosis: study of epidermal growth factor and steroid receptors. Br J Dermatol (1995) 0.86
Hysterectomy in women with cervical pregnancy complicated by life-threatening bleeding: a case report. Clin Exp Obstet Gynecol (1997) 0.85
Effects of fluoxetine on wild and mutant neuronal alpha 7 nicotinic receptors. Mol Psychiatry (1998) 0.85
Cellular receptors for sex steroids in human pituitary adenomas. J Endocrinol (1996) 0.85
Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects. J Steroid Biochem (1973) 0.85
Type 1 diabetes mellitus and hyperadrenocorticism in a ferret. Vet Res Commun (2010) 0.85
Isolated precocious pubarche: an approach. J Clin Endocrinol Metab (1994) 0.85
Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res (1978) 0.85
Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation. Neuroscience (2002) 0.84
Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal Quant Cytol Histol (2001) 0.84
Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens. Steroids (1998) 0.84
The desensitization of the embryonic mouse muscle acetylcholine receptor depends on the cellular environment. Pflugers Arch (1995) 0.84
Transforming growth factor-beta expression in prostate neoplasia. Anal Quant Cytol Histol (2000) 0.84
Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Dig Liver Dis (2001) 0.84
Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine. Can J Physiol Pharmacol (1990) 0.84
Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int J Impot Res (2008) 0.84
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. J Clin Endocrinol Metab (2001) 0.84
Religious and spiritual beliefs in outpatients suffering from Parkinson Disease. Int J Geriatr Psychiatry (2010) 0.84
Diagnosing erectile dysfunction: the penile dynamic colour duplex ultrasound revisited. Int J Androl (2005) 0.84
Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor. Br J Pharmacol (1999) 0.84
Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies. J Cell Physiol (2008) 0.83
Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter. Endocrinology (2000) 0.83
Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH). J Androl (1998) 0.83
Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition. J Endocrinol Invest (2004) 0.82
Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Endocr Relat Cancer (2008) 0.82
A clinician looks at androgen resistance. Steroids (1996) 0.82
Cervical intraepithelial neoplasia and bacterial vaginosis: correlation or risk factor? Eur J Gynaecol Oncol (1997) 0.82